Update date: Jul 08, 2026 | 100 Pages | Report ID: HO-003564
Organ Preservation Market
DMA IntelligenceOrgan Preservation Demand Analysis & Forecast Outlook 2033
Segments: Solution (University of Wisconsin (UW), Custodiol HTK, Perfadex, Others), Organ Type (Kidneys, Liver, Lung, Heart, Others), Preservation Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others), By Region, And Segment Forecasts
$2000.0M
Market Size, 2025
$2150.0M
Market Estimate, 2026
$3567.0M
Market Forecast, 2033
7.5%
CAGR, 2026–2033
Organ Preservation Market Size, Share & Key Insights
The Organ Preservation Market size was valued at USD 2000.00 Million in 2025, and the market is projected to grow from USD 2150.00 Million in 2026 to USD 3566.96 Million by 2033, growing at a CAGR of 7.5% during the forecast period 2026–2033. The market saw distributed global demand in 2025.
Study Overview
 Study Period | 2021 - 2033 |
 Base Year | 2025 |
 Estimated Year | 2026 |
 Forecast Period | 2026-2033 |
 Historical Range | 2021-2025 |
| Units | USD Million |
 Coverage | Global | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
 Deliverables | PDF + Excel Data Pack |
Major Market Players
Key Insights
- The global Organ Preservation market is projected to grow from USD 2000.00 Million in 2025 to USD 3568.10 Million by 2033, demonstrating a robust CAGR of 7.50% during the forecast period.
- Static cold storage continues to dominate the market, holding the largest share in 2025, while machine perfusion techniques are expected to exhibit the fastest growth due to superior organ viability and extended preservation times.
- North America is currently the largest market for organ preservation, driven by advanced healthcare infrastructure and high transplant volumes, whereas Asia Pacific is anticipated to emerge as the fastest-growing region, fueled by increasing medical tourism and improving healthcare access.
Market Definition and Strategic Context
The Organ Preservation Market refers to the specialized medical field focused on technologies and methods used to maintain the viability and functionality of organs between retrieval from a donor and transplantation into a recipient. This critical process is essential for successful organ transplantation, addressing the challenges of ischemia-reperfusion injury, cellular degradation, and immunological responses. The market encompasses a range of solutions, including static cold storage, machine perfusion, and various preservation solutions, all designed to extend the ex-vivo lifespan of organs like kidneys, livers, hearts, and lungs. The global Organ Preservation market size was valued at USD 2000.00 Million in 2025 and is projected to exhibit significant industry expansion over the forecast period. Driven by the increasing prevalence of end-stage organ diseases, a rising number of organ donations, and advancements in preservation techniques, the market is poised for robust growth. The growth outlook for the Organ Preservation market is further bolstered by continuous research and development efforts aimed at improving organ quality, reducing discard rates, and expanding the donor pool. Strategic investments in innovative technologies, such as normothermic machine perfusion, are enhancing the efficacy and safety of transplantation procedures. The market forecast indicates a sustained upward trajectory, supported by growing awareness, favorable regulatory environments, and the global demand for life-saving organ transplants. As healthcare systems strive for better patient outcomes and optimized resource utilization, the Organ Preservation market plays a pivotal role in advancing transplant medicine and improving the lives of patients awaiting new organs.
| Report Attribute | Details |
|---|---|
| Market size value in 2025 | USD 2,000.00 Million |
| Revenue forecast in 2033 | USD 3,566.96 Million |
| Growth rate | CAGR of 7.5% from 2025 to 2033 |
| Actual data | 2021 - 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD Million and CAGR from 2025 to 2033 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | Solution, Organ Type, Preservation Technique |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
| Key companies profiled | XVIVO; TransMedics, Inc; 21st Century Medicine; Bridge to Life Ltd; Preservation Solutions, Inc; Global Transplant Solutions; Organ Recovery Systems; CryoLife, Inc. (Artivion, Inc); Paragonix Technologies, Inc (Getinge) |
| Customization scope | Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Growth Catalysts & Market Constraints
The Organ Preservation market is shaped by a confluence of factors influencing its expansion and posing challenges. A significant driver is the global rise in chronic diseases leading to organ failure, necessitating a greater number of transplant procedures. Technological advancements in preservation solutions and techniques, particularly machine perfusion, are extending organ viability, thus expanding the window for transplantation and reducing organ discard rates. However, the market also faces constraints such as the high cost of advanced preservation technologies and a persistent shortage of donor organs. These dynamics create a complex landscape, where innovation must balance with economic accessibility and ethical considerations to sustain the Organ Preservation market's growth trajectory and address unmet medical needs effectively.
Growth Drivers
- The increasing global incidence of end-stage organ diseases, such as kidney failure, liver cirrhosis, and heart failure, is a primary driver for the Organ Preservation market. This surge directly translates into a higher demand for organ transplantation, thereby boosting the need for effective preservation solutions that ensure organ viability during transport and storage, enabling more successful surgical outcomes.
- Advancements in organ preservation technologies, particularly the evolution from static cold storage to dynamic machine perfusion techniques, significantly contribute to market growth. These innovative methods improve organ quality assessment, extend preservation times, and reduce ischemia-reperfusion injury, ultimately increasing the number of transplantable organs and improving patient survival rates.
Restraints
- The high cost associated with advanced organ preservation technologies, especially machine perfusion devices and specialized solutions, acts as a significant restraint. These substantial expenses can limit adoption in healthcare systems with budget constraints, particularly in developing regions, thereby hindering market expansion and equitable access to optimal preservation methods.
- A persistent global shortage of donor organs remains a fundamental constraint on the Organ Preservation market. Despite technological improvements in preservation, the limited availability of suitable organs directly impacts the volume of transplant procedures, thereby capping the overall market potential for preservation solutions and equipment.
Opportunities
- Emerging markets in Asia Pacific and Latin America present significant growth opportunities due to their rapidly developing healthcare infrastructure, increasing medical tourism, and a growing awareness of organ donation. Strategic partnerships with local healthcare providers and investment in regional distribution networks can unlock substantial untapped market potential.
- Further advancements in ex-vivo organ repair and reconditioning technologies offer a substantial opportunity for market players. Innovations that can rejuvenate marginal organs or treat pre-existing conditions during the preservation phase could significantly expand the donor pool, reduce organ discard rates, and enhance transplantation success.
Challenges
- Ensuring regulatory compliance and navigating complex approval processes across different countries poses a significant challenge for companies operating in the Organ Preservation market. Varied regulatory standards and lengthy clinical trial requirements can delay market entry for new products and increase development costs, impacting profitability and innovation timelines.
- The logistical complexities of organ retrieval, preservation, and transportation within strict timeframes present an ongoing challenge. Maintaining the cold chain, ensuring rapid deployment of preservation devices, and coordinating across multiple healthcare facilities requires robust infrastructure and highly skilled personnel, which can be difficult to scale globally.
Market Level Breakdown
The Organ Preservation market is broadly segmented by Solution, encompassing static cold storage, machine perfusion, normothermic regional perfusion, and other innovative solutions. Static cold storage remains a foundational method due to its simplicity and cost-effectiveness, contributing significantly to market size. However, machine perfusion is gaining traction for its ability to continuously perfuse organs, potentially improving viability and enabling better assessment before transplantation. Normothermic regional perfusion represents an advanced technique that aims to mimic physiological conditions, offering promising avenues for extending preservation times and improving outcomes, reflecting the market's continuous drive towards more sophisticated methods.
Further segmentation by Organ Type highlights the specific requirements for preserving different organs, including kidneys, livers, hearts, lungs, and pancreas. Kidneys constitute the largest segment due to the high incidence of renal failure and established transplant procedures. Liver and heart preservation techniques are critical given the organs' sensitivity and the urgency of transplantation. Each organ type demands tailored preservation protocols and solutions to optimize post-transplant function, driving specialized product development and contributing to the diverse nature of the Organ Preservation market landscape.
The market is also segmented by Preservation Technique, which further refines the understanding of technological preferences and clinical applications. This includes a detailed analysis of the various methods employed for different organs. The choice of preservation technique often depends on factors such as organ type, anticipated ischemia time, and the logistical challenges involved. Understanding these technique-specific trends is crucial for market players to develop targeted solutions that meet the evolving needs of transplant centers globally, ensuring effective and safe organ preservation.
Organ Preservation Segmentation Breakdown
- Solution
- University of Wisconsin (UW)
- Custodiol HTK
- Perfadex
- Others
- Organ Type
- Kidneys
- Liver
- Lung
- Heart
- Others
- Preservation Technique
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Others
Geographic Performance & Regional Trends
North America currently stands as the largest market for organ preservation, a position attributed to its advanced healthcare infrastructure, high awareness regarding organ donation, and a significant number of transplant centers and procedures. This region benefits from robust government funding for medical research and a strong presence of key market players. Concurrently, the Asia Pacific region is identified as the fastest-growing market, driven by improving healthcare access, increasing medical tourism, and a rising prevalence of chronic diseases necessitating organ transplantation. The region's growth in the Organ Preservation market is further supported by a growing number of initiatives aimed at increasing organ donation rates and adopting advanced medical technologies.
Regional Growth Drivers
- North America: The region's leadership in the Organ Preservation market is primarily driven by highly developed healthcare systems, substantial R&D investments in transplant medicine, and a strong regulatory framework supporting organ donation and transplantation. Countries like the United States and Canada benefit from high transplant volumes and rapid adoption of advanced preservation technologies, including machine perfusion, ensuring superior organ viability.
- Europe: Growth in Europe is fueled by increasing awareness campaigns for organ donation, favorable reimbursement policies for transplant procedures, and a collaborative research environment. Countries such as Germany, the United Kingdom, and France are at the forefront, actively implementing advanced preservation techniques and expanding their transplant programs to address the rising demand for life-saving organs.
- Asia Pacific: This region is experiencing rapid growth due to improving healthcare infrastructure, rising disposable incomes, and a growing patient pool suffering from end-stage organ diseases. Key countries like China, Japan, and India are investing heavily in modernizing their transplant capabilities and adopting sophisticated organ preservation solutions, driven by increasing medical tourism and government support.
- Latin America: The Organ Preservation market in Latin America is driven by ongoing healthcare reforms, increasing access to advanced medical treatments, and efforts to standardize transplant protocols. Countries such as Brazil and Mexico are witnessing a rise in transplant volumes and a gradual adoption of modern preservation technologies, aiming to improve patient outcomes and expand their regional medical services.
- Middle East & Africa: Growth in this region is primarily propelled by increasing healthcare expenditure, a focus on upgrading medical facilities, and rising prevalence of chronic diseases. Countries like Saudi Arabia and South Africa are investing in specialized transplant centers and enhancing their organ preservation capabilities to address local health challenges and improve access to critical care.
The regional forecast indicates a sustained shift towards emerging markets, with Asia Pacific poised to capture a larger share of the Organ Preservation market in the coming years. While mature markets like North America and Europe will continue to innovate and refine existing techniques, growth will be more pronounced in regions where healthcare infrastructure is rapidly expanding and patient access to advanced treatments is improving. This trajectory suggests strategic implications for suppliers, emphasizing the need for localized market penetration strategies, investment in regional distribution networks, and adaptation of product offerings to cater to diverse economic and regulatory landscapes, ultimately fostering global market expansion.
Competitive Insights & Leading Companies
The Organ Preservation competitive landscape is characterized by a moderately consolidated structure, featuring a mix of established global players and specialized regional companies. Key market participants differentiate themselves through continuous innovation in preservation solutions, advanced machine perfusion technologies, and strategic partnerships with transplant centers. Competitive levers include product efficacy, extended preservation times, ease of use, and regulatory approvals across diverse geographies. Global players often leverage their extensive R&D capabilities and broad distribution networks to maintain market leadership, while smaller, agile companies focus on niche segments or disruptive technologies. The market sees intense competition in areas like novel preservation fluids and portable perfusion devices, where technological superiority can significantly influence market share. Furthermore, the ability to navigate complex regulatory pathways and secure timely product certifications is crucial for market penetration and sustained growth in this specialized medical field, ensuring that new solutions meet stringent safety and efficacy standards globally.
Strategic initiatives within the Organ Preservation market frequently involve mergers and acquisitions aimed at consolidating market share, expanding product portfolios, and gaining access to new technologies or geographical markets. Product launches, particularly of next-generation machine perfusion systems and specialized preservation fluids, are common strategies to enhance competitive positioning. Companies are also focusing on geographic expansion, particularly into high-growth regions like Asia Pacific, to tap into increasing demand for transplant services. R&D investments are paramount, centered on improving organ viability, reducing discard rates, and developing solutions for challenging organ types. Differentiation often stems from clinical evidence demonstrating superior outcomes, comprehensive training and support services for transplant teams, and the ability to offer integrated solutions that cover the entire organ donation and transplantation pathway. However, the market faces challenges such as margin pressure due to the high cost of R&D and manufacturing, along with the need to continuously adapt to evolving clinical guidelines and ethical considerations in organ transplantation, which can impact strategic planning and market entry decisions.
Organ Preservation Key Companies
- XVIVO
- TransMedics, Inc
- 21st Century Medicine
- Bridge to Life Ltd
- Preservation Solutions, Inc
- Global Transplant Solutions
- Organ Recovery Systems
- CryoLife, Inc. (Artivion, Inc)
- Paragonix Technologies, Inc (Getinge)
Organ Preservation Market Ecosystem
Ecosystem Participants
- Organ Procurement Organizations (OPOs) — Responsible for identifying potential organ donors, obtaining consent, coordinating organ recovery, and managing the logistical aspects of organ allocation and transportation. They serve as a crucial link between donors and transplant centers, ensuring the timely and ethical provision of organs for preservation.
- OPOs collaborate closely with hospitals, medical staff, and transplant teams to facilitate the entire donation process, often operating under strict regulatory guidelines to maximize the number of viable organs available for transplant.
- Transplant Centers/Hospitals — End-users of organ preservation technologies, where transplantation surgeries are performed. These institutions utilize preservation solutions and devices to maintain organ viability from retrieval until implantation, playing a critical role in patient care and post-operative monitoring.
- Transplant centers make purchasing decisions for preservation equipment and solutions, often driving demand for advanced technologies based on clinical outcomes, surgeon preferences, and institutional budgets. They are also involved in research and development of new techniques.
- Medical Device Manufacturers — Companies that design, develop, and produce organ preservation solutions, devices (e.g., machine perfusion systems, static cold storage containers), and related accessories. They innovate to extend preservation times, improve organ viability, and reduce discard rates.
- These manufacturers invest heavily in R&D, clinical trials, and regulatory approvals to bring advanced products to market. They also provide technical support, training, and maintenance services to transplant centers, forming a key supply side of the ecosystem.
- Research & Academic Institutions — Involved in fundamental and applied research to understand organ physiology, develop new preservation methods, and improve existing technologies. They contribute to the scientific basis of organ preservation and often collaborate with industry partners.
- These institutions conduct studies on novel preservation fluids, hypothermic and normothermic perfusion strategies, and ex-vivo organ repair, publishing findings that influence clinical practice and guide future product development.
- Government & Regulatory Bodies — Agencies responsible for setting guidelines, regulations, and policies related to organ donation, procurement, preservation, and transplantation. They ensure ethical standards, safety, and efficacy of medical devices and procedures.
- Regulatory bodies like the FDA or EMA provide essential oversight, approving new preservation technologies for market use and monitoring their performance, thereby impacting market access and product development timelines for manufacturers.
- Pharmaceutical Companies — Develop and supply specialized preservation solutions, anti-rejection medications, and other pharmacological agents used during organ preservation and post-transplant care to minimize immune responses and improve graft survival.
- Their involvement extends to creating solutions that reduce cellular damage during ischemia and reperfusion, providing crucial chemical components for effective organ maintenance and contributing to overall transplant success.
Report Coverage & Key Deliverables
The report delivers a comprehensive analysis of the Organ Preservation, combining quantitative data with qualitative insights. This exhaustive study provides decision-makers with a deep understanding of the market's current state, historical performance, and future growth trajectories. It offers a strategic roadmap for stakeholders, enabling them to identify emerging opportunities, assess competitive threats, and formulate effective business strategies. The report's scope covers a detailed examination of market size, growth drivers, restraints, and key trends influencing the industry. By presenting a holistic view of the Organ Preservation landscape, it equips businesses with the critical intelligence needed to make informed investment decisions, optimize product development, and navigate the complex regulatory environment, ensuring clarity and precision in market understanding.
Report Coverage
- Market Size Estimates (historical and forecast)
- The report provides meticulous market size estimates spanning from 2021 to 2033, covering both historical data and future projections. These estimates are derived through a rigorous methodology involving primary and secondary research, triangulated with industry expert opinions to ensure accuracy and reliability for strategic planning.
- Detailed Segmentation And Revenue Analysis
- A granular breakdown of the Organ Preservation market is presented across various segments, including solution type, organ type, and preservation technique. Each segment's revenue contribution and growth potential are analyzed, offering insights into market dynamics and attractive investment pockets.
- Regional And Country-Level Insights
- The study offers in-depth analysis of market performance across key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, along with specific country-level data. This allows for a comparative understanding of market maturity, growth drivers, and regulatory landscapes in different geographies.
- Competitive Benchmarking Of Key Players
- A comprehensive assessment of the competitive landscape, including profiles of leading companies, their strategic initiatives, product portfolios, and market positioning. This section helps stakeholders understand competitive intensity, identify key differentiators, and benchmark their performance against industry leaders.
- Customization Options Based on Specific Requirements
- Clients have the flexibility to customize the report based on their unique research needs, including adding specific country analysis, deeper dives into particular segments, or competitive intelligence on additional companies. This ensures the report delivers maximum value and relevance to individual business objectives.
Recent Industry Insights
The Organ Preservation industry trends have seen significant developments over the last 12-18 months, reflecting a concerted effort to enhance transplant outcomes and expand donor organ viability. Innovations in machine perfusion technology continue to be a driving force, with several companies launching next-generation devices promising longer preservation times and improved organ assessment. Strategic partnerships between medical device manufacturers and transplant centers are becoming more common, aiming to integrate advanced preservation solutions into clinical practice more seamlessly. Regulatory bodies are also adapting, with some regions streamlining approval processes for novel preservation techniques, thereby accelerating market access. Furthermore, increasing public awareness campaigns for organ donation, coupled with technological advancements, are collectively shaping a dynamic and evolving Organ Preservation market landscape, fostering optimism for future growth and improved patient care.
Key Market Developments
- March 2025: TransMedics, Inc. announced expansion of its OCS Heart system availability across more transplant centers in the United States, enhancing access to its advanced heart preservation technology.
- January 2025: XVIVO received regulatory approval in Japan for its perfusion solution, expanding its footprint in the Asia Pacific market and addressing a growing demand for advanced preservation fluids.
- November 2024: Paragonix Technologies, Inc. partnered with a leading European hospital network to implement its SherpaPak Cardiac Transport System across their transplant programs, aiming to standardize cold storage for hearts in Germany and France.
- September 2024: A consortium of European research institutions published new clinical data supporting the efficacy of normothermic regional perfusion for liver transplants, highlighting its potential to expand the donor pool.
Analyst Opinion
The Organ Preservation market outlook remains highly attractive, driven by an undeniable and growing global need for organ transplantation. The competitive intensity, while robust, is channeled primarily into innovation, with companies striving to offer solutions that extend organ viability, improve assessment, and ultimately enhance transplant success rates. We observe a healthy demand-supply balance in terms of technological advancements, as the continuous innovation in preservation techniques directly addresses the critical shortage of viable donor organs. The market is not just expanding in size but also in sophistication, with a clear shift towards dynamic preservation methods like machine perfusion that offer superior outcomes compared to traditional static cold storage. This evolution is crucial for optimizing the utilization of retrieved organs and reducing the high discard rates, thereby maximizing the life-saving potential of every donation. The ongoing research into ex-vivo organ repair and reconditioning further underscores the market's potential for transformative growth, promising to reshape transplant medicine significantly.
Looking at the long-term outlook, the Organ Preservation market is poised for sustained growth, underpinned by demographic shifts, increasing prevalence of chronic diseases, and a global rise in awareness and acceptance of organ donation. The innovation landscape is vibrant, with significant R&D investments in areas such as artificial intelligence for organ assessment, bioengineering for organ regeneration, and advanced personalized preservation protocols. Key risk factors include the high cost of advanced technologies, which could impede adoption in less affluent regions, and the persistent ethical and logistical challenges associated with organ procurement. However, strategic collaborations between public and private entities, coupled with evolving regulatory frameworks, are expected to mitigate these risks. Suppliers must focus on developing cost-effective yet highly efficient solutions, expanding their global footprint, and fostering strong relationships with transplant communities to capitalize on the immense potential of this life-saving industry.